Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

Cobra wins Adenovirus contract in buoyant EU biotech sector

01-Sep-2009 - Cobra Biomanufacturing’s new Adenovirus manufacturing and process services contract is further evidence of the health of EU biologicals market, according to business development manager Philip Ridley-Smith.

Nanostructure catalysts could save pharma time & money

01-Sep-2009 - Researchers believe they are a step closer to creating superefficient industrial catalysts after a team made platinum-on-gold bimetallic nanorods that are soluble in organic solvents.

Mantecorp installs tech to cut energy use

26-Aug-2009 - Mantecorp is using the Control and Communication Link (CC-Link) open fieldbus network to improve the environmental credentials of its facility in Rio de Janeiro, Brazil.

GEA wins €15m order from China’s Hisun Pharmaceutical

20-Aug-2009 - GEA Lyophil, part of GEA Pharma Systems, has won a contract to supply Chinjese drugmaker Zheijang Hisun Pharmaceutical with freeze drying systems and automatic loading units.

Sani-Tech tubing could be boost for bio

12-Aug-2009 - Biotech processes will be improved by using Sani-Tech Ultra tubing, according to its manufacturer that claims the product has a longer lifespan and lower concentration of extractables than its competitors.

Downstream demand helps Millipore’s Q2

10-Aug-2009 - Demand for downstream processing products from biotechs drove the continued recovery of Millipore’s bioprocessing division in Q2 but operating income remained flat.

SAFC and SSB step towards “totally disposable factory”

16-Jul-2009 - SAFC’s bioscience unit and Sartorius Stedim Biotech (SSB) have teamed up to create a suite of fluid management solutions that they hope will prove irresistible to the booming biomanufacturing sector.

ISO 9001 accreditation a “huge step” for Prosonix

07-Jul-2009 - Ultrasonic particle engineering specialist Prosonix has been accredited under the ISO 9001:2008 quality scheme, after an inspection by the UK unit of independent auditing group SGS.

Pfizer plans Irish process lab, shelves SF unit and sells skin drugs to Graceway

07-Jul-2009 - Pfizer will invest €11m ($15.3m) in a new kilo technology R&D laboratory at its API manufacturing facility in Ringaskiddy, Ireland.

Novasep buys to get big in bio

06-Jul-2009 - Novasep has bolstered its upstream processing capabilities by acquiring Henogen, a Belgium-based CMO that has biotech development and cGMP manufacturing expertise.

TFS and Siemens hope to have process analysis down PAT

01-Jul-2009 - US group Thermo Fisher Scientific and industrial engineering giant Siemens have teamed up to offer the pharmaceutical industry a new way of assessing processes used during early drug development, manufacturing scale up and commercial production.

TFC forms JV to boost DMSO output

30-Jun-2009 - Rising demand in China has led to Toray Fine Chemicals (TFC) establishing a joint venture to produce dimethylsulfoxide (DMSO), a reaction solvent in pharma production.

Sanyo claims H202 steralised incubator is industry first

25-Jun-2009 - Sanyo Biomedical and Environmental Solutions claims the H202 steralisation approach used by its Steisonic CxP MCO-19AIC(UVH) cell incubator system is an industry first and effective replacement for ethylene oxide (EtO).

Helsinn plans for HPAPI manufacture

23-Jun-2009 - Swiss drugmaker Helsinn has unveiled plans to add high-potency API R&D and manufacturing capacity to its facility in Biasca in the south of the country.

Millipore’s Massachusetts Mobius plant open for business

22-Jun-2009 - Millipore has ramped up capacity for its Mobius range of single use bio-processing and manufacturing technologies with a new purpose built production facility in Danvers, Massachusetts.

Lonza’s GS system wins Elusys anthrax Ab contract

16-Jun-2009 - Swiss life sciences solutions firm Lonza has been contracted by US biotechnology group Elusys Therapeutics to produce Anthim, its late stage Ab candidate treatment for anthrax infection.

Alfa hopes to make industrial chemistry an ART

11-Jun-2009 - Sweden’s Alfa Laval says ART PR49, its combined chemical reactor and heat transfer plate, improves the efficiency of chemical production and helps reduce energy costs.

FDA revises ICH Q8 guidance

10-Jun-2009 - The FDA has revised its guidance on ICH Q8, adding an annex that clarifies the original document and adds the principles of quality by design (QbD).

Sanofi swoops for Pfizer insulin plant, scuppering MannKind's bid

09-Jun-2009 - Sanofi Aventis will pay Pfizer €30m ($41m) for a former Exubera manufacturing plant in Frankfurt-Höchst, Germany that was due to be bought by inhaled insulin specialist MannKind.

Kemwell & Boehringer collaborate on biologics

09-Jun-2009 - CMO Kemwell is receiving technical assistance from Boehringer Ingelheim for the construction of its new biotech facility, which is designed to marry European technology with Indian low cost manufacturing.

Upfront boasts 60% yield boost in processing step

25-May-2009 - CMO Richter-Helm BioLogics has achieved a 60 per cent increase in yield using technology from Upfront Chromatography, which demonstrated its system at BIO 2009.

Telstar unveils vial unloading system at Achema

18-May-2009 - Telstar unveiled a range of products at Achema 2009 in Frankfurt, Germany last week, including its compact unloading system that forms part of its automatic vial loading system and aims to minimise installation space.

Orbital bioreactors set to shake up mammalian cell culture sector

13-May-2009 - ExcellGene’s OrbShake 250L mammalian cell culture bioreactor has equalled biomass productivity and oxygenation levels previously only achieved by traditional stirred tank systems.

News in brief

Boost for Belgian biomanufacture “fundamental” says Genzyme

11-May-2009 - Biotechnology group Genzyme will boost biomanufacturing capacity at its plant in Geel, Belgium in a move that is “fundamentally important to future growth” according to site VP Sandra Poole.

PharmaTek OKed to make cytotoxics at San Diego plant

07-May-2009 - US chemistry firm PharmaTek Laboratories has a green light to start making high potency APIs and cytotoxics at its facility in California after meeting strict safety and control rules that govern their production.

Sign up for your free newsletter